chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Anal incontinence, Asthenia, COVID-19, Cardiac hypertrophy, Chest X-ray abnormal
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 01/07/21 COVID vaccine dose #1 02/01/21 COVID vaccine dose #2 06/11/21 Suspected recurrence of adenocarcinoma RUL; pt prefers to wait 3 months and re-evaluate 07/24/21 Pt presents to ED reporting cough, general weakness x7 days, dry cough, shortness of breath, occasional headache; COVID POSITIVE, chronic elevated troponin with no chest pain, CXR and CT head wnl; admitted inpatient 07/25/21 Pt reports congestion, dry cough, and intermittent left sided chest pain; CT brain wnl 07/26/21 Pt reports cough improved and overall feeling better; ECHO revealed normal left ventricle size with severe concentric hypertrophy, LVEF 35-40% 07/27/21 Pt discharged with rx for DM/guiafenesin, lisinopril, polyethylene glycol, albuterol/ipratropium 07/30/21 Pt reported to not be eating or drinking and has diarrhea; reports extremely fatigued; advised to stop miralax 08/01/21 Pt remains weak but stable, reports BP is low; diarrhea has lessened but has bowel/bladder incontinence 08/02/21 Pt is improving, reports fatigue 08/04/21 Daughter calls into CCC reporting low BP 83/49; presents to ED reporting weakness and fatigue with shortness of breath and decrease PO intake; CT head wnl, CXR indicative of pneumonia; treated with IV fluids and discharged with rx for azithromycin, thiamine; advised to decrease dose of lisinopril to 10mg 08/05/21 Daughter reports difficulty in splitting tablet and has held BP medication due to low BP readings in the 70-80s/40-50s
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Computerised tomogram head normal, Cough, Diarrhoea, Dyspnoea
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 01/07/21 COVID vaccine dose #1 02/01/21 COVID vaccine dose #2 06/11/21 Suspected recurrence of adenocarcinoma RUL; pt prefers to wait 3 months and re-evaluate 07/24/21 Pt presents to ED reporting cough, general weakness x7 days, dry cough, shortness of breath, occasional headache; COVID POSITIVE, chronic elevated troponin with no chest pain, CXR and CT head wnl; admitted inpatient 07/25/21 Pt reports congestion, dry cough, and intermittent left sided chest pain; CT brain wnl 07/26/21 Pt reports cough improved and overall feeling better; ECHO revealed normal left ventricle size with severe concentric hypertrophy, LVEF 35-40% 07/27/21 Pt discharged with rx for DM/guiafenesin, lisinopril, polyethylene glycol, albuterol/ipratropium 07/30/21 Pt reported to not be eating or drinking and has diarrhea; reports extremely fatigued; advised to stop miralax 08/01/21 Pt remains weak but stable, reports BP is low; diarrhea has lessened but has bowel/bladder incontinence 08/02/21 Pt is improving, reports fatigue 08/04/21 Daughter calls into CCC reporting low BP 83/49; presents to ED reporting weakness and fatigue with shortness of breath and decrease PO intake; CT head wnl, CXR indicative of pneumonia; treated with IV fluids and discharged with rx for azithromycin, thiamine; advised to decrease dose of lisinopril to 10mg 08/05/21 Daughter reports difficulty in splitting tablet and has held BP medication due to low BP readings in the 70-80s/40-50s
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram abnormal, Ejection fraction decreased, Fatigue, Headache, Hypophagia
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 01/07/21 COVID vaccine dose #1 02/01/21 COVID vaccine dose #2 06/11/21 Suspected recurrence of adenocarcinoma RUL; pt prefers to wait 3 months and re-evaluate 07/24/21 Pt presents to ED reporting cough, general weakness x7 days, dry cough, shortness of breath, occasional headache; COVID POSITIVE, chronic elevated troponin with no chest pain, CXR and CT head wnl; admitted inpatient 07/25/21 Pt reports congestion, dry cough, and intermittent left sided chest pain; CT brain wnl 07/26/21 Pt reports cough improved and overall feeling better; ECHO revealed normal left ventricle size with severe concentric hypertrophy, LVEF 35-40% 07/27/21 Pt discharged with rx for DM/guiafenesin, lisinopril, polyethylene glycol, albuterol/ipratropium 07/30/21 Pt reported to not be eating or drinking and has diarrhea; reports extremely fatigued; advised to stop miralax 08/01/21 Pt remains weak but stable, reports BP is low; diarrhea has lessened but has bowel/bladder incontinence 08/02/21 Pt is improving, reports fatigue 08/04/21 Daughter calls into CCC reporting low BP 83/49; presents to ED reporting weakness and fatigue with shortness of breath and decrease PO intake; CT head wnl, CXR indicative of pneumonia; treated with IV fluids and discharged with rx for azithromycin, thiamine; advised to decrease dose of lisinopril to 10mg 08/05/21 Daughter reports difficulty in splitting tablet and has held BP medication due to low BP readings in the 70-80s/40-50s
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Lung adenocarcinoma recurrent, Lung opacity, Pneumonia, Respiratory tract congestion
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 01/07/21 COVID vaccine dose #1 02/01/21 COVID vaccine dose #2 06/11/21 Suspected recurrence of adenocarcinoma RUL; pt prefers to wait 3 months and re-evaluate 07/24/21 Pt presents to ED reporting cough, general weakness x7 days, dry cough, shortness of breath, occasional headache; COVID POSITIVE, chronic elevated troponin with no chest pain, CXR and CT head wnl; admitted inpatient 07/25/21 Pt reports congestion, dry cough, and intermittent left sided chest pain; CT brain wnl 07/26/21 Pt reports cough improved and overall feeling better; ECHO revealed normal left ventricle size with severe concentric hypertrophy, LVEF 35-40% 07/27/21 Pt discharged with rx for DM/guiafenesin, lisinopril, polyethylene glycol, albuterol/ipratropium 07/30/21 Pt reported to not be eating or drinking and has diarrhea; reports extremely fatigued; advised to stop miralax 08/01/21 Pt remains weak but stable, reports BP is low; diarrhea has lessened but has bowel/bladder incontinence 08/02/21 Pt is improving, reports fatigue 08/04/21 Daughter calls into CCC reporting low BP 83/49; presents to ED reporting weakness and fatigue with shortness of breath and decrease PO intake; CT head wnl, CXR indicative of pneumonia; treated with IV fluids and discharged with rx for azithromycin, thiamine; advised to decrease dose of lisinopril to 10mg 08/05/21 Daughter reports difficulty in splitting tablet and has held BP medication due to low BP readings in the 70-80s/40-50s
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Troponin increased, Urinary incontinence
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 01/07/21 COVID vaccine dose #1 02/01/21 COVID vaccine dose #2 06/11/21 Suspected recurrence of adenocarcinoma RUL; pt prefers to wait 3 months and re-evaluate 07/24/21 Pt presents to ED reporting cough, general weakness x7 days, dry cough, shortness of breath, occasional headache; COVID POSITIVE, chronic elevated troponin with no chest pain, CXR and CT head wnl; admitted inpatient 07/25/21 Pt reports congestion, dry cough, and intermittent left sided chest pain; CT brain wnl 07/26/21 Pt reports cough improved and overall feeling better; ECHO revealed normal left ventricle size with severe concentric hypertrophy, LVEF 35-40% 07/27/21 Pt discharged with rx for DM/guiafenesin, lisinopril, polyethylene glycol, albuterol/ipratropium 07/30/21 Pt reported to not be eating or drinking and has diarrhea; reports extremely fatigued; advised to stop miralax 08/01/21 Pt remains weak but stable, reports BP is low; diarrhea has lessened but has bowel/bladder incontinence 08/02/21 Pt is improving, reports fatigue 08/04/21 Daughter calls into CCC reporting low BP 83/49; presents to ED reporting weakness and fatigue with shortness of breath and decrease PO intake; CT head wnl, CXR indicative of pneumonia; treated with IV fluids and discharged with rx for azithromycin, thiamine; advised to decrease dose of lisinopril to 10mg 08/05/21 Daughter reports difficulty in splitting tablet and has held BP medication due to low BP readings in the 70-80s/40-50s
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Diarrhoea
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 03/10/21 COVID vaccine dose #1 03/31/21 COVID vaccine dose #2 04/05/21 COVID swab performed preop - NEGATIVE 07/22/21 Pt reports cough, congestion, headache, dizziness, loss of taste/smell; COVID POSITIVE 07/23/21 Pt reports diarrhea, fatigue, fever, runny nose; rx given for acetaminophen, DM/guaifenesin, loperamide 07/25/21 Pt reports very little cough, improving fatigue, continued loss of taste/smell; "feeling better every day" 07/26/21 Pt reports postnasal drip but is improving
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Pyrexia, Respiratory tract congestion
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 03/10/21 COVID vaccine dose #1 03/31/21 COVID vaccine dose #2 04/05/21 COVID swab performed preop - NEGATIVE 07/22/21 Pt reports cough, congestion, headache, dizziness, loss of taste/smell; COVID POSITIVE 07/23/21 Pt reports diarrhea, fatigue, fever, runny nose; rx given for acetaminophen, DM/guaifenesin, loperamide 07/25/21 Pt reports very little cough, improving fatigue, continued loss of taste/smell; "feeling better every day" 07/26/21 Pt reports postnasal drip but is improving
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Upper-airway cough syndrome
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 03/10/21 COVID vaccine dose #1 03/31/21 COVID vaccine dose #2 04/05/21 COVID swab performed preop - NEGATIVE 07/22/21 Pt reports cough, congestion, headache, dizziness, loss of taste/smell; COVID POSITIVE 07/23/21 Pt reports diarrhea, fatigue, fever, runny nose; rx given for acetaminophen, DM/guaifenesin, loperamide 07/25/21 Pt reports very little cough, improving fatigue, continued loss of taste/smell; "feeling better every day" 07/26/21 Pt reports postnasal drip but is improving
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Dyspnoea exertional, Exposure to SARS-CoV-2
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 06/07/21 COVID vaccine dose #1 07/22/21 Pt reports cough, muscle pain, and rhinorrhea x2 days; exposed to positive COVID church member; swab performed - COVID POSITIVE 07/23/21 Pt reports loss of taste/smell, cough, muscle pain, runny nose; rx given for DM/guaifenesin 07/24/21 Pt reports dry cough, frontal headache, muscle pain, rhinorrhea 07/25/21 Pt reports mild cough, returning loss of taste/smell, muscle pain, runny nose 07/26/21 Pt reports fatigue 07/27/21 Pt reports mild productive cough 07/28/21 Pt reports cough improving 07/29/21 Pt reports SOB on exertion, improving cough 07/30/21 Pt reports continued loss of taste/smell; isolation end
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Productive cough, Rhinorrhoea
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 06/07/21 COVID vaccine dose #1 07/22/21 Pt reports cough, muscle pain, and rhinorrhea x2 days; exposed to positive COVID church member; swab performed - COVID POSITIVE 07/23/21 Pt reports loss of taste/smell, cough, muscle pain, runny nose; rx given for DM/guaifenesin 07/24/21 Pt reports dry cough, frontal headache, muscle pain, rhinorrhea 07/25/21 Pt reports mild cough, returning loss of taste/smell, muscle pain, runny nose 07/26/21 Pt reports fatigue 07/27/21 Pt reports mild productive cough 07/28/21 Pt reports cough improving 07/29/21 Pt reports SOB on exertion, improving cough 07/30/21 Pt reports continued loss of taste/smell; isolation end
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 06/07/21 COVID vaccine dose #1 07/22/21 Pt reports cough, muscle pain, and rhinorrhea x2 days; exposed to positive COVID church member; swab performed - COVID POSITIVE 07/23/21 Pt reports loss of taste/smell, cough, muscle pain, runny nose; rx given for DM/guaifenesin 07/24/21 Pt reports dry cough, frontal headache, muscle pain, rhinorrhea 07/25/21 Pt reports mild cough, returning loss of taste/smell, muscle pain, runny nose 07/26/21 Pt reports fatigue 07/27/21 Pt reports mild productive cough 07/28/21 Pt reports cough improving 07/29/21 Pt reports SOB on exertion, improving cough 07/30/21 Pt reports continued loss of taste/smell; isolation end
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 12/31/20 COVID vaccine dose #1 01/21/21 COVID vaccine dose #2 07/22/21 Pt called office reporting COVID POSITIVE test from place, requesting test through agency; reports slight cough but no fever or other symptoms; COVID POSITIVE 07/23/21 Pt reports cough, runny nose but is stable; rx given for DM/guaifenesin 07/26/21 Pt is stable and improving
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Aphasia, Asthenia, Bronchitis, COVID-19, Chest X-ray normal
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 01/05/21 COVID vaccine dose #1 01/27/21 COVID vaccine dose #2 03/24/21 Pt presents to ED reporting left sided neck pain and swelling x3-4 weeks; labs wnl, CT negative; discharged home and advised to continue to use tylenol 04/29/21 Pt presents to ED reporting productive cough with green sputum, intermitten SOB; denies fever, chills, N/V/D, loss of taste/smell; CXR wnl, COVID NEGATIVE; discharged home with rx for albuterol, DM/guiafenesin, azithromycin for bronchitis 05/26/21 COVID NEGATIVE preop 07/23/21 Pt presents to ED reporting weakness, nausea and near syncope x3 days, CXR wnl; treated with IV fluids and discharged for mild dehydration; COVID POSITIVE 07/25/21 Pt reports headache, diminished taste/smell; describes shortness of breath that is normal for him 07/26/21 Pt reports tachypnic and is advised to go to ER 07/27/21 Wife reports pt was sent home from community ED as O2 sat and CXR wnl but pt remains short of breath and unable to complete sentences; o2 sat 96%; reports mild, infrequent cough, fatigue, poor appetite, nausea, vomiting, single episode of diarrhea; rx given for albuterol, famotidine 07/28/21 Pt reports fever (temp 100.9), diarrhea, vomiting; rx given for loperamide and ondansetron 07/30/21 Pt reports doing better, O2 sat 96 08/01/21 Pt reports fatigue and some shortness of breath 08/03/21 Pt is improving and meets CDC criteria for resolution
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram normal, Decreased appetite, Dehydration, Diarrhoea, Dyspnoea
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 01/05/21 COVID vaccine dose #1 01/27/21 COVID vaccine dose #2 03/24/21 Pt presents to ED reporting left sided neck pain and swelling x3-4 weeks; labs wnl, CT negative; discharged home and advised to continue to use tylenol 04/29/21 Pt presents to ED reporting productive cough with green sputum, intermitten SOB; denies fever, chills, N/V/D, loss of taste/smell; CXR wnl, COVID NEGATIVE; discharged home with rx for albuterol, DM/guiafenesin, azithromycin for bronchitis 05/26/21 COVID NEGATIVE preop 07/23/21 Pt presents to ED reporting weakness, nausea and near syncope x3 days, CXR wnl; treated with IV fluids and discharged for mild dehydration; COVID POSITIVE 07/25/21 Pt reports headache, diminished taste/smell; describes shortness of breath that is normal for him 07/26/21 Pt reports tachypnic and is advised to go to ER 07/27/21 Wife reports pt was sent home from community ED as O2 sat and CXR wnl but pt remains short of breath and unable to complete sentences; o2 sat 96%; reports mild, infrequent cough, fatigue, poor appetite, nausea, vomiting, single episode of diarrhea; rx given for albuterol, famotidine 07/28/21 Pt reports fever (temp 100.9), diarrhea, vomiting; rx given for loperamide and ondansetron 07/30/21 Pt reports doing better, O2 sat 96 08/01/21 Pt reports fatigue and some shortness of breath 08/03/21 Pt is improving and meets CDC criteria for resolution
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypogeusia, Hyposmia, Laboratory test normal
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 01/05/21 COVID vaccine dose #1 01/27/21 COVID vaccine dose #2 03/24/21 Pt presents to ED reporting left sided neck pain and swelling x3-4 weeks; labs wnl, CT negative; discharged home and advised to continue to use tylenol 04/29/21 Pt presents to ED reporting productive cough with green sputum, intermitten SOB; denies fever, chills, N/V/D, loss of taste/smell; CXR wnl, COVID NEGATIVE; discharged home with rx for albuterol, DM/guiafenesin, azithromycin for bronchitis 05/26/21 COVID NEGATIVE preop 07/23/21 Pt presents to ED reporting weakness, nausea and near syncope x3 days, CXR wnl; treated with IV fluids and discharged for mild dehydration; COVID POSITIVE 07/25/21 Pt reports headache, diminished taste/smell; describes shortness of breath that is normal for him 07/26/21 Pt reports tachypnic and is advised to go to ER 07/27/21 Wife reports pt was sent home from community ED as O2 sat and CXR wnl but pt remains short of breath and unable to complete sentences; o2 sat 96%; reports mild, infrequent cough, fatigue, poor appetite, nausea, vomiting, single episode of diarrhea; rx given for albuterol, famotidine 07/28/21 Pt reports fever (temp 100.9), diarrhea, vomiting; rx given for loperamide and ondansetron 07/30/21 Pt reports doing better, O2 sat 96 08/01/21 Pt reports fatigue and some shortness of breath 08/03/21 Pt is improving and meets CDC criteria for resolution
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Neck pain, Presyncope, Productive cough, Pyrexia
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 01/05/21 COVID vaccine dose #1 01/27/21 COVID vaccine dose #2 03/24/21 Pt presents to ED reporting left sided neck pain and swelling x3-4 weeks; labs wnl, CT negative; discharged home and advised to continue to use tylenol 04/29/21 Pt presents to ED reporting productive cough with green sputum, intermitten SOB; denies fever, chills, N/V/D, loss of taste/smell; CXR wnl, COVID NEGATIVE; discharged home with rx for albuterol, DM/guiafenesin, azithromycin for bronchitis 05/26/21 COVID NEGATIVE preop 07/23/21 Pt presents to ED reporting weakness, nausea and near syncope x3 days, CXR wnl; treated with IV fluids and discharged for mild dehydration; COVID POSITIVE 07/25/21 Pt reports headache, diminished taste/smell; describes shortness of breath that is normal for him 07/26/21 Pt reports tachypnic and is advised to go to ER 07/27/21 Wife reports pt was sent home from community ED as O2 sat and CXR wnl but pt remains short of breath and unable to complete sentences; o2 sat 96%; reports mild, infrequent cough, fatigue, poor appetite, nausea, vomiting, single episode of diarrhea; rx given for albuterol, famotidine 07/28/21 Pt reports fever (temp 100.9), diarrhea, vomiting; rx given for loperamide and ondansetron 07/30/21 Pt reports doing better, O2 sat 96 08/01/21 Pt reports fatigue and some shortness of breath 08/03/21 Pt is improving and meets CDC criteria for resolution
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sputum discoloured, Swelling, Tachypnoea, Vomiting
Clinical narrative: Narrative:  COVID infections following completion of COVID vaccine series 01/05/21 COVID vaccine dose #1 01/27/21 COVID vaccine dose #2 03/24/21 Pt presents to ED reporting left sided neck pain and swelling x3-4 weeks; labs wnl, CT negative; discharged home and advised to continue to use tylenol 04/29/21 Pt presents to ED reporting productive cough with green sputum, intermitten SOB; denies fever, chills, N/V/D, loss of taste/smell; CXR wnl, COVID NEGATIVE; discharged home with rx for albuterol, DM/guiafenesin, azithromycin for bronchitis 05/26/21 COVID NEGATIVE preop 07/23/21 Pt presents to ED reporting weakness, nausea and near syncope x3 days, CXR wnl; treated with IV fluids and discharged for mild dehydration; COVID POSITIVE 07/25/21 Pt reports headache, diminished taste/smell; describes shortness of breath that is normal for him 07/26/21 Pt reports tachypnic and is advised to go to ER 07/27/21 Wife reports pt was sent home from community ED as O2 sat and CXR wnl but pt remains short of breath and unable to complete sentences; o2 sat 96%; reports mild, infrequent cough, fatigue, poor appetite, nausea, vomiting, single episode of diarrhea; rx given for albuterol, famotidine 07/28/21 Pt reports fever (temp 100.9), diarrhea, vomiting; rx given for loperamide and ondansetron 07/30/21 Pt reports doing better, O2 sat 96 08/01/21 Pt reports fatigue and some shortness of breath 08/03/21 Pt is improving and meets CDC criteria for resolution
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: 3 patients received 0.5 ml of pfizer.
Age: 13.0
Sex: U
Vaccine: MMRV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: @MMRV given at age 13 not 12 years old.
Sex: U
Vaccine: MMRV
Symptoms: Wrong product administered
Clinical narrative: MMRV was given instead of MMR and Varicella separately
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Diarrhoea, Dyspnoea exertional, Pulmonary arterial hypertension
Clinical narrative: Describe Event, Problem, or Product Use Error: {Johnson and Johnson vaccine] use for COVID-19 UNDER Emergency Use Authorization (EUA): Patient reported to MD that she felt increased exertional dyspnea and PAH related symptoms after receiving the vaccine, several months ago. She also reports morning cough and morning diarrhea, that may be related to Tadalafil use. The patient is also on Ambrisentan for PAH management.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Breast pain, Injection site pain, Musculoskeletal pain, Pain in extremity
Clinical narrative: Booster shot symptoms of higher than moderate pain spread through left side injection site to wrist, armpit and breast tissue and to shoulder blade. Sinuses throb, temples tender.
Sex: F
Vaccine: COVID19
Symptoms: Sinus disorder, Tenderness
Clinical narrative: Booster shot symptoms of higher than moderate pain spread through left side injection site to wrist, armpit and breast tissue and to shoulder blade. Sinuses throb, temples tender.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: My two Moderna vaccinations were painless and uneventful. When I got the Moderna booster, there was a sudden severe pain inside my arm when she stuck me.  I've never felt anything like that with any injection in my entire life. it made me jump, and I never move during injections. Ever since then, I've had bad arm pain.  It's a severe ache.  It's been almost six weeks, and it has not diminished.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Patient had adverse reaction to Botox and covid vaccine and will have delay in botox treatment per doctor request due to adverse reaction.
Sex: F
Vaccine: COVID19
Symptoms: Injection site reaction, Lymph node pain, Lymphadenopathy
Clinical narrative: approximately 24h after receiving the COVID-19 Pfizer vaccine booster, i presented with swollen and painful lymph nodes on the injection arm. These lymph nodes were located on the proximal side of the upper arm.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Flushing
Clinical narrative: Blood pressure increased 185/110-tachycardia- taking medication for this currently; Felt funny inside my chest; Heaviness inside my chest; I felt like I couldn't catch my breath.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose increased, Blood pressure increased, Chest X-ray normal, Chest discomfort, Dyspnoea
Clinical narrative: Blood pressure increased 185/110-tachycardia- taking medication for this currently; Felt funny inside my chest; Heaviness inside my chest; I felt like I couldn't catch my breath.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, SARS-CoV-2 test negative, Tachycardia
Clinical narrative: Blood pressure increased 185/110-tachycardia- taking medication for this currently; Felt funny inside my chest; Heaviness inside my chest; I felt like I couldn't catch my breath.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome
Clinical narrative: A previously healthy 22 year-old male presented with progressive weakness in all extremities nine days after receiving his first dose of the Moderna COVID-19 vaccine. He required intubation for respiratory failure and was treated with plasma exchange for five days without improvement. Two months following onset, he was readmitted from a nursing facility to another hospital and treated for ventilator-associated pneumonia (VAP) and pericarditis. EMG showed generalized, non-length dependent AMAN; CSF showed elevated protein. Lumbar spine MRI revealed cauda equina and conus medullaris enhancement with paraspinal muscular edema. He received a five-day course of intravenous immunoglobulin, then was admitted to long-term acute care and weaned from the ventilator. Four months following onset, he transitioned to inpatient rehabilitation where he stayed for just over a month. At time of discharge home, biceps and triceps had active but partial range of motion, hip flexors had trace activation, and quadriceps remained flaccid.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Guillain-Barre syndrome, Immunoglobulin therapy, Laboratory test, Lumbar puncture
Clinical narrative: A previously healthy 22 year-old male presented with progressive weakness in all extremities nine days after receiving his first dose of the Moderna COVID-19 vaccine. He required intubation for respiratory failure and was treated with plasma exchange for five days without improvement. Two months following onset, he was readmitted from a nursing facility to another hospital and treated for ventilator-associated pneumonia (VAP) and pericarditis. EMG showed generalized, non-length dependent AMAN; CSF showed elevated protein. Lumbar spine MRI revealed cauda equina and conus medullaris enhancement with paraspinal muscular edema. He received a five-day course of intravenous immunoglobulin, then was admitted to long-term acute care and weaned from the ventilator. Four months following onset, he transitioned to inpatient rehabilitation where he stayed for just over a month. At time of discharge home, biceps and triceps had active but partial range of motion, hip flexors had trace activation, and quadriceps remained flaccid.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mechanical ventilation, Obstructive airways disorder, Paralysis, Plasmapheresis
Clinical narrative: A previously healthy 22 year-old male presented with progressive weakness in all extremities nine days after receiving his first dose of the Moderna COVID-19 vaccine. He required intubation for respiratory failure and was treated with plasma exchange for five days without improvement. Two months following onset, he was readmitted from a nursing facility to another hospital and treated for ventilator-associated pneumonia (VAP) and pericarditis. EMG showed generalized, non-length dependent AMAN; CSF showed elevated protein. Lumbar spine MRI revealed cauda equina and conus medullaris enhancement with paraspinal muscular edema. He received a five-day course of intravenous immunoglobulin, then was admitted to long-term acute care and weaned from the ventilator. Four months following onset, he transitioned to inpatient rehabilitation where he stayed for just over a month. At time of discharge home, biceps and triceps had active but partial range of motion, hip flexors had trace activation, and quadriceps remained flaccid.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute motor axonal neuropathy, CSF protein increased, Cauda equina syndrome, Conus medullaris syndrome, Electromyogram abnormal
Clinical narrative: A previously healthy 22 year-old male presented with progressive weakness in all extremities nine days after receiving his first dose of the Moderna COVID-19 vaccine. He required intubation for respiratory failure and was treated with plasma exchange for five days without improvement. Two months following onset, he was readmitted from a nursing facility to another hospital and treated for ventilator-associated pneumonia (VAP) and pericarditis. EMG showed generalized, non-length dependent AMAN; CSF showed elevated protein. Lumbar spine MRI revealed cauda equina and conus medullaris enhancement with paraspinal muscular edema. He received a five-day course of intravenous immunoglobulin, then was admitted to long-term acute care and weaned from the ventilator. Four months following onset, he transitioned to inpatient rehabilitation where he stayed for just over a month. At time of discharge home, biceps and triceps had active but partial range of motion, hip flexors had trace activation, and quadriceps remained flaccid.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Hypotonia, Immunoglobulin therapy, Joint range of motion decreased, Magnetic resonance imaging spinal abnormal
Clinical narrative: A previously healthy 22 year-old male presented with progressive weakness in all extremities nine days after receiving his first dose of the Moderna COVID-19 vaccine. He required intubation for respiratory failure and was treated with plasma exchange for five days without improvement. Two months following onset, he was readmitted from a nursing facility to another hospital and treated for ventilator-associated pneumonia (VAP) and pericarditis. EMG showed generalized, non-length dependent AMAN; CSF showed elevated protein. Lumbar spine MRI revealed cauda equina and conus medullaris enhancement with paraspinal muscular edema. He received a five-day course of intravenous immunoglobulin, then was admitted to long-term acute care and weaned from the ventilator. Four months following onset, he transitioned to inpatient rehabilitation where he stayed for just over a month. At time of discharge home, biceps and triceps had active but partial range of motion, hip flexors had trace activation, and quadriceps remained flaccid.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscle oedema, Muscular weakness, Pericarditis, Plasmapheresis, Pneumonia
Clinical narrative: A previously healthy 22 year-old male presented with progressive weakness in all extremities nine days after receiving his first dose of the Moderna COVID-19 vaccine. He required intubation for respiratory failure and was treated with plasma exchange for five days without improvement. Two months following onset, he was readmitted from a nursing facility to another hospital and treated for ventilator-associated pneumonia (VAP) and pericarditis. EMG showed generalized, non-length dependent AMAN; CSF showed elevated protein. Lumbar spine MRI revealed cauda equina and conus medullaris enhancement with paraspinal muscular edema. He received a five-day course of intravenous immunoglobulin, then was admitted to long-term acute care and weaned from the ventilator. Four months following onset, he transitioned to inpatient rehabilitation where he stayed for just over a month. At time of discharge home, biceps and triceps had active but partial range of motion, hip flexors had trace activation, and quadriceps remained flaccid.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Respiratory failure, Wean from ventilator
Clinical narrative: A previously healthy 22 year-old male presented with progressive weakness in all extremities nine days after receiving his first dose of the Moderna COVID-19 vaccine. He required intubation for respiratory failure and was treated with plasma exchange for five days without improvement. Two months following onset, he was readmitted from a nursing facility to another hospital and treated for ventilator-associated pneumonia (VAP) and pericarditis. EMG showed generalized, non-length dependent AMAN; CSF showed elevated protein. Lumbar spine MRI revealed cauda equina and conus medullaris enhancement with paraspinal muscular edema. He received a five-day course of intravenous immunoglobulin, then was admitted to long-term acute care and weaned from the ventilator. Four months following onset, he transitioned to inpatient rehabilitation where he stayed for just over a month. At time of discharge home, biceps and triceps had active but partial range of motion, hip flexors had trace activation, and quadriceps remained flaccid.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cardiac aneurysm, Catheterisation cardiac, Chest pain, Computerised tomogram thorax, Electrocardiogram
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2021 16:00 (Lot number: EN6200) at the age of 72 years as dose 2, single and administered in arm left, administration date 29Jan2021 (Lot number: EL9265) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Onions" (unspecified if ongoing), notes: Known allergies: Onions. There were no concomitant medications. The following information was reported: CARDIAC DISORDER (hospitalization, disability, life threatening), INFLAMMATION (hospitalization, disability, life threatening) all with onset 25Feb2021 12:00, outcome "not recovered" and all described as "Major heart inflammation"; MYOCARDITIS (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "Myocarditis"; CARDIAC ANEURYSM (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "FIVE heart Aneurysms"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 05Nov2021, outcome "unknown" and all described as "covid test date=05Nov2021, covid test result=Positive". The patient was hospitalized for cardiac disorder, inflammation, myocarditis, cardiac aneurysm (hospitalization duration: 2 day(s)). The events "major heart inflammation", "major heart inflammation", "myocarditis" and "five heart aneurysms" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: computerised tomogram: (unspecified date) unknown result; sars-cov-2 test: (05Nov2021) positive, notes: Nasal Swab; x-ray: (unspecified date) unknown result. Therapeutic measures were taken as a result of cardiac disorder, inflammation, myocarditis, cardiac aneurysm.  Clinical Course: Facility type vaccine: Doctor's office/urgent care. Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage.  No follow-up attempts are possible. No further information was expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Laboratory test, Magnetic resonance imaging heart, Myocarditis, Ultrasound scan
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2021 16:00 (Lot number: EN6200) at the age of 72 years as dose 2, single and administered in arm left, administration date 29Jan2021 (Lot number: EL9265) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Onions" (unspecified if ongoing), notes: Known allergies: Onions. There were no concomitant medications. The following information was reported: CARDIAC DISORDER (hospitalization, disability, life threatening), INFLAMMATION (hospitalization, disability, life threatening) all with onset 25Feb2021 12:00, outcome "not recovered" and all described as "Major heart inflammation"; MYOCARDITIS (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "Myocarditis"; CARDIAC ANEURYSM (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "FIVE heart Aneurysms"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 05Nov2021, outcome "unknown" and all described as "covid test date=05Nov2021, covid test result=Positive". The patient was hospitalized for cardiac disorder, inflammation, myocarditis, cardiac aneurysm (hospitalization duration: 2 day(s)). The events "major heart inflammation", "major heart inflammation", "myocarditis" and "five heart aneurysms" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: computerised tomogram: (unspecified date) unknown result; sars-cov-2 test: (05Nov2021) positive, notes: Nasal Swab; x-ray: (unspecified date) unknown result. Therapeutic measures were taken as a result of cardiac disorder, inflammation, myocarditis, cardiac aneurysm.  Clinical Course: Facility type vaccine: Doctor's office/urgent care. Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage.  No follow-up attempts are possible. No further information was expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Cardiac aneurysm, Cardiac disorder, Computerised tomogram, Inflammation
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2021 16:00 (Lot number: EN6200) at the age of 72 years as dose 2, single and administered in arm left, administration date 29Jan2021 (Lot number: EL9265) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Onions" (unspecified if ongoing), notes: Known allergies: Onions. There were no concomitant medications. The following information was reported: CARDIAC DISORDER (hospitalization, disability, life threatening), INFLAMMATION (hospitalization, disability, life threatening) all with onset 25Feb2021 12:00, outcome "not recovered" and all described as "Major heart inflammation"; MYOCARDITIS (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "Myocarditis"; CARDIAC ANEURYSM (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "FIVE heart Aneurysms"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 05Nov2021, outcome "unknown" and all described as "covid test date=05Nov2021, covid test result=Positive". The patient was hospitalized for cardiac disorder, inflammation, myocarditis, cardiac aneurysm (hospitalization duration: 2 day(s)). The events "major heart inflammation", "major heart inflammation", "myocarditis" and "five heart aneurysms" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: computerised tomogram: (unspecified date) unknown result; sars-cov-2 test: (05Nov2021) positive, notes: Nasal Swab; x-ray: (unspecified date) unknown result. Therapeutic measures were taken as a result of cardiac disorder, inflammation, myocarditis, cardiac aneurysm.  Clinical Course: Facility type vaccine: Doctor's office/urgent care. Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage.  No follow-up attempts are possible. No further information was expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Myocarditis, SARS-CoV-2 test, Vaccination failure, X-ray
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2021 16:00 (Lot number: EN6200) at the age of 72 years as dose 2, single and administered in arm left, administration date 29Jan2021 (Lot number: EL9265) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Onions" (unspecified if ongoing), notes: Known allergies: Onions. There were no concomitant medications. The following information was reported: CARDIAC DISORDER (hospitalization, disability, life threatening), INFLAMMATION (hospitalization, disability, life threatening) all with onset 25Feb2021 12:00, outcome "not recovered" and all described as "Major heart inflammation"; MYOCARDITIS (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "Myocarditis"; CARDIAC ANEURYSM (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "FIVE heart Aneurysms"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 05Nov2021, outcome "unknown" and all described as "covid test date=05Nov2021, covid test result=Positive". The patient was hospitalized for cardiac disorder, inflammation, myocarditis, cardiac aneurysm (hospitalization duration: 2 day(s)). The events "major heart inflammation", "major heart inflammation", "myocarditis" and "five heart aneurysms" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: computerised tomogram: (unspecified date) unknown result; sars-cov-2 test: (05Nov2021) positive, notes: Nasal Swab; x-ray: (unspecified date) unknown result. Therapeutic measures were taken as a result of cardiac disorder, inflammation, myocarditis, cardiac aneurysm.  Clinical Course: Facility type vaccine: Doctor's office/urgent care. Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage.  No follow-up attempts are possible. No further information was expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cardiac aneurysm, Cardiac discomfort, Catheterisation cardiac abnormal, Chest X-ray abnormal, Chest pain
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2021 16:00 (Lot number: EN6200) at the age of 72 years as dose 2, single and administered in arm left, administration date 29Jan2021 (Lot number: EL9265) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Onions" (unspecified if ongoing), notes: Known allergies: Onions. There were no concomitant medications. The following information was reported: CARDIAC DISORDER (hospitalization, disability, life threatening), INFLAMMATION (hospitalization, disability, life threatening) all with onset 25Feb2021 12:00, outcome "not recovered" and all described as "Major heart inflammation"; MYOCARDITIS (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "Myocarditis"; CARDIAC ANEURYSM (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "FIVE heart Aneurysms"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 05Nov2021, outcome "unknown" and all described as "covid test date=05Nov2021, covid test result=Positive". The patient was hospitalized for cardiac disorder, inflammation, myocarditis, cardiac aneurysm (hospitalization duration: 2 day(s)). The events "major heart inflammation", "major heart inflammation", "myocarditis" and "five heart aneurysms" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: computerised tomogram: (unspecified date) unknown result; sars-cov-2 test: (05Nov2021) positive, notes: Nasal Swab; x-ray: (unspecified date) unknown result. Therapeutic measures were taken as a result of cardiac disorder, inflammation, myocarditis, cardiac aneurysm.  Clinical Course: Facility type vaccine: Doctor's office/urgent care. Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage.  No follow-up attempts are possible. No further information was expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram abnormal, Dyspnoea, Magnetic resonance imaging heart, Myocarditis
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2021 16:00 (Lot number: EN6200) at the age of 72 years as dose 2, single and administered in arm left, administration date 29Jan2021 (Lot number: EL9265) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Onions" (unspecified if ongoing), notes: Known allergies: Onions. There were no concomitant medications. The following information was reported: CARDIAC DISORDER (hospitalization, disability, life threatening), INFLAMMATION (hospitalization, disability, life threatening) all with onset 25Feb2021 12:00, outcome "not recovered" and all described as "Major heart inflammation"; MYOCARDITIS (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "Myocarditis"; CARDIAC ANEURYSM (hospitalization, disability, life threatening) with onset 25Feb2021 12:00, outcome "not recovered", described as "FIVE heart Aneurysms"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 05Nov2021, outcome "unknown" and all described as "covid test date=05Nov2021, covid test result=Positive". The patient was hospitalized for cardiac disorder, inflammation, myocarditis, cardiac aneurysm (hospitalization duration: 2 day(s)). The events "major heart inflammation", "major heart inflammation", "myocarditis" and "five heart aneurysms" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: computerised tomogram: (unspecified date) unknown result; sars-cov-2 test: (05Nov2021) positive, notes: Nasal Swab; x-ray: (unspecified date) unknown result. Therapeutic measures were taken as a result of cardiac disorder, inflammation, myocarditis, cardiac aneurysm.  Clinical Course: Facility type vaccine: Doctor's office/urgent care. Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage.  No follow-up attempts are possible. No further information was expected.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient died after contracting COVID-19 late September 2021.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Patient died after contracting COVID-19 late September 2021.